Merck
MRK
#47
Rank
C$441.49 B
Marketcap
C$178.75
Share price
-0.10%
Change (1 day)
59.80%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$4.87

According to Merck's latest financial reports the company's current EPS (TTM) is C$4.99. In 2025 the company made an earnings per share (EPS) of C$10.22 an increase over its 2024 EPS that were of C$9.48.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.87-52.3%
2025C$10.227.81%
2024C$9.484308.46%
2023C$0.21-97.32%
2022C$8.0310.92%
2021C$7.2484.68%
2020C$3.92-27.2%
2019C$5.3963.44%
2018C$3.30151.11%
2017C$1.31-54.58%
2016C$2.8930.21%
2015C$2.22-61.99%
2014C$5.84180.51%
2013C$2.08-31.82%
2012C$3.056.62%
2011C$2.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.25 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.84 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.84-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.06 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.57 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.30 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.59-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$4.99 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.45 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.92-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel